𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion

✍ Scribed by Louise Flanagan; Kathryn Packman; Brian Juba; Sharon O’Neill; Martin Tenniswood; JoEllen Welsh

Book ID
117668474
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
604 KB
Volume
84
Category
Article
ISSN
0960-0760

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-8 modulates growth and invas
Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells
✍ Chen Yao; Ying Lin; Mei-Sze Chua; Cai-Sheng Ye; Jiong Bi; Wen Li; Yi-Fan Zhu; Sh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 439 KB

## Abstract Breast cancer, especially estrogen receptor (ER)‐negative breast cancer, remains hard to treat despite major advances in surgery and adjuvant therapies. The deletion of ER has been consistently associated with tumor progression, recurrence, metastasis and poor prognosis. Among other dif

The role of human epidermal growth facto
The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004
✍ Monica Brown; Alex Tsodikov; Katrina R. Bauer; Carol A. Parise; Vincent Caggiano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

## Abstract ## BACKGROUND Breast cancers that are negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (triple negative [TN]) have been associated with high‐grade histology, aggressive clinical behavior, and poor survival. It has been